2004
DOI: 10.1111/j.1526-4610.2004.04011.x
|View full text |Cite
|
Sign up to set email alerts
|

Migraine: A Chronic Sympathetic Nervous System Disorder

Abstract: The major finding of the present study is that migraine is a disorder of chronic sympathetic dysfunction, sharing many diagnostic and clinical characteristics with pure autonomic failure and multiple system atrophy. However, the sympathetic nervous system dysfunction in migraine differs from pure autonomic failure and multiple system atrophy in that occurs in an anatomically intact system. It is proposed that the sympathetic dysfunction in migraine relates to an imbalance of sympathetic co-transmitters. Specif… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
168
0
4

Year Published

2006
2006
2020
2020

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 208 publications
(180 citation statements)
references
References 47 publications
5
168
0
4
Order By: Relevance
“…Although these results suggest that the adrenergic system does not play a significant role in neurogenic dural vasodilatation, the porcine studies mentioned above do suggest that α-adrenoceptor agonists should still be considered for the development of potential antimigraine drugs. Moreover, studies on human subjects suggest that migraineurs have sympathetic hypofunction (Boccuni et al 1989;Peroutka 2004). Accordingly, drugs targeting on subtypes of α 1 -adrenoceptors, which lack systemic vasoconstriction, could hold a promising future in antimigraine therapy.…”
Section: Adrenoceptorsmentioning
confidence: 99%
“…Although these results suggest that the adrenergic system does not play a significant role in neurogenic dural vasodilatation, the porcine studies mentioned above do suggest that α-adrenoceptor agonists should still be considered for the development of potential antimigraine drugs. Moreover, studies on human subjects suggest that migraineurs have sympathetic hypofunction (Boccuni et al 1989;Peroutka 2004). Accordingly, drugs targeting on subtypes of α 1 -adrenoceptors, which lack systemic vasoconstriction, could hold a promising future in antimigraine therapy.…”
Section: Adrenoceptorsmentioning
confidence: 99%
“…Thus, P2X 3 receptor antagonists may be candidates for antimigraine drug development (Waeber and Moskowitz, 2003). There is also recent evidence that migraine is a chronic sympathetic nervous system disorder, with which there is an increase in release of sympathetic cotransmitters, including ATP (Peroutka, 2004), which may contribute to the initial vasospasm (Macdonald, 2000).…”
Section: B Migrainementioning
confidence: 99%
“…Studies have investigated the pathophysiological mechanisms of headache, focusing on the autonomic functions [5,17]. These evaluations of autonomic functions utilized data on blood pressure or pulse rate.…”
Section: Discussionmentioning
confidence: 99%
“…These symptoms suggest that autonomic dysfunctions are taking place in patients with migraine [4,5]. Reports have been published regarding fluctuation of blood pressure or heart rate variability (HRV) in patients with migraine, but no general agreement has yet been obtained [6].…”
Section: Introductionmentioning
confidence: 99%